Gastroenteritis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
Condition:   Human Papillomavirus Infection Interventions:   Biological: Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli);   Biological: GARDASIL® 9 Sponsors:   Beijing Health Guard Biotechnology, Inc;   Yunnan Center for Disease Control and Prevention;   Mile City Center for Disease Control and Prevention;   Qiubei County Center for Disease Control and Prevention;   Yanshan County Center for Disease Control and Prevention;   National Ins titutes for Food and Drug Control, China;   Shanghai Stem Pharmaceutical Development Co., Ltd. Activ...
Source: ClinicalTrials.gov - December 22, 2022 Category: Research Source Type: clinical trials